Crossmark

Validation of the ALBI-TAE model and comparison of seven scoring systems for predicting survival outcome in patients with intermediate‐stage hepatocellular carcinoma undergoing chemoembolization

Crossref DOI link: https://doi.org/10.1186/s40644-023-00575-6

Published Online: 2023-05-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bannangkoon, Kittipitch https://orcid.org/0000-0003-1926-5239
Hongsakul, Keerati

Tubtawee, Teeravut
License Information

Text and Data Mining valid from 2023-05-30

Version of Record valid from 2023-05-30
More Information

Article History

Received: 8 December 2022

Accepted: 22 May 2023

First Online: 30 May 2023

Declarations

:

: Patient consent was waived as the study was a retrospective study.

: The authors have no conflicts of interest to declare.

Document is current

Any future updates will be listed below